Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a strategic agreement to accelerate the development of new targeted therapies that respond to unmet ...
Read more
This is a Biotech company founded in 2006 by Dr. Jordi Mestres as a spin-off from the Hospital del Mar Medical Research Institute (IMIM)
Read more
With the new incorporation, the company consolidates its transition from a software business to an AI-driven biotech
Read more
This month Sifted, the technology magazine of the Financial Times, has contacted various experts in the technology industry and in analyzing data on investments, has concluded that the Spanish entrepr...
Read more
The company Chemotargets –based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform– has signed a strategic agreeme...
Read more
Chemotargets -a global leader in the development of intelligence platforms and drug design prediction, headquartered in the Barcelona Science Park- has signed a license agreement for its CLARITY® pla...
Read more
Chemotargets, a global leader in predictive analytics solutions for the pharma and biotech sector, begins a phase of transformation to become a biotechnology company that will develop new medicines...
Read more
GENESIS Biomed and CREA Inversión will advise in the funding, which will allow the company to expand its activity in the discovery of new drugs
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
An intellectually active lifestyle — in other words, the so-called c...
